Your browser doesn't support javascript.
loading
Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach.
Burman, William; Rucsineanu, Oxana; Horsburgh, C Robert; Johnston, James; Dorman, Susan E; Menzies, Dick.
Afiliação
  • Burman W; Public Health Institute at Denver Health and the Department of Medicine, University of Colorado, Denver, Colorado, United States of America.
  • Rucsineanu O; Moldova National Association of Tuberculosis Patients "SMIT" (Society of Moldova against Tuberculosis), Balti, Moldova; Global TB Community Advisory Board, New York, New York, United States of America.
  • Horsburgh CR; Departments of Global Health, Epidemiology, Biostatistics and Medicine, Schools of Public Health and Medicine, Boston University, Boston Massachusetts, United States of America.
  • Johnston J; Division of Respiratory Medicine, University of British Columbia, Vancouver, Canada.
  • Dorman SE; Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
  • Menzies D; McGill International TB Centre, Montreal Chest Institute, Research Institute of the McGill University Health Centre, Montreal, Canada.
PLoS Med ; 21(7): e1004438, 2024 Jul.
Article em En | MEDLINE | ID: mdl-39052666

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose / Antituberculosos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose / Antituberculosos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article